Bicara Therapeutics Down Nearly 46%, on Track for Record Percent Decrease -- Data Talk
Dow Jones2026/10/28 16:46Bicara Therapeutics Inc. (BCAX) is currently at $9.47, down $8.01 or 45.82%
--Would be lowest close since July 8, 2025, when it closed at $9.26
--Would be largest percent decrease on record (Based on available data back to Sept. 13, 2024)
--Currently down five of the past six days
--Down 49.11% month-to-date; on pace for worst month on record (Based on available data back to Sept. 13, 2024)
--Down 43.73% year-to-date; on pace for worst year on record (Based on available data back to Sept. 13, 2024)
--Down 68.85% from its all-time closing high of $30.40 on July 7, 2026
--Down 40.37% from 52 weeks ago (Oct. 29, 2025), when it closed at $15.88
--Down 68.85% from its 52-week closing high of $30.40 on July 7, 2026
--Would be a new 52-week closing low
--Traded as low as $8.90; lowest intraday level since July 7, 2025, when it hit $8.74
--Down 49.08% at today's intraday low; largest intraday percent decrease since May 23, 2025, when it fell as much as 50.19%
All data as of 12:44:28 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 28, 2026 12:46 ET (16:46 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.
WikiLeaks Founder Julian Assange Welcomes Daughter With Terminator Quote